Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02544061 · ClinicalTrials.gov registry record · Phase 2
NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds
A Phase 2 study, sponsored by Neumedicines.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT02544061: Completed Phase 2 study, sponsored by Neumedicines.
NCT02544061 is a Phase 2 study that has completed, run by Neumedicines. The registered enrollment target is 18 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02544061, a Phase 2 study, has completed, sponsored by Neumedicines.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and tolerability of NM-IL-12 relative to standard of care (SOC; control) in subjects with open surgical wounds.
Primary Outcome
Number of subjects with adverse events as a measure of safety and tolerability
Interventions
- DRUG Placebo
- BIOLOGICAL NM-IL-12
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2018-02-28 |
| Phase | Phase 2 |
What the finished NCT02544061 record still lists
NCT02544061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02544061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02544061 about?
NCT02544061 is a clinical study titled "NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds". The purpose of this study is to determine the safety and tolerability of NM-IL-12 relative to standard of care (SOC; control) in subjects with open surgical wounds.
What is the current status of trial NCT02544061?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2016-03-01. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT02544061?
The interventions under investigation include: Placebo (DRUG), NM-IL-12 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02544061?
This trial is sponsored by Neumedicines, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02544061's enrollment target sits among peer trials
18 1898th of 2000 higher than 98 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI